CHARLOTTE, N.C., July 02, 2025 (GLOBE NEWSWIRE) -- Hemp Hop has announced the launch of 2 new high-THCa strains - London ...

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a presentation and discussion on immunotherapies involving AIM’s drug Ampligen at the recent U.S.-Poland Science and ...

Together, Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven add 30 satellite locations to enroll patients in BriaCell’s pivotal Phase 3 study ...

Primo Biotechnology Co., Ltd., a pioneering radiopharmaceutical company in Taiwan, announced the successful completion of its NT$220 million Series A funding round. With total capital raised now ...

If istaroxime is approved in the US for acute heart failure, this patent would provide protection to 2039 ...

LEWISVILLE, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- Middlesex Recovery, a provider of office-based opioid treatment for substance use disorders, has introduced a brand refresh that reflects its ...

This strategic partnership is part of SurgiBox's global expansion strategy, which aims to make safe surgery accessible to patients worldwide, particularly in regions where maintaining safe surgical ...

This brand refresh includes a modernized logo that represents the winding pathway to recovery and the support AppleGate provides at every step. The visual update showcases the brand’s connection to a ...

Under the agreement, Cronos will supply PEACE NATURALS ® -branded cannabis flower to Dascoli for distribution across its established medical network in Switzerland. This strategic collaboration marks ...

As part of this announcement, Hyperion DeFi’s co-branded validator ‘Kinetiq x Hyperion’ is officially live. The Company has started to stake its HYPE holdings to generate yield and further prepare for ...

Torys LLP acted as legal advisor to Extendicare in connection with the Transaction. Origin Merchant Partners acted as financial advisor to Closing the Gap and Aird & Berlis LLP acted as legal advisor ...

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced that it expects to implement a 1 ...